Amicus Therapeutics Inc (FOLD)
10.42
0.00 (0.00%)
USD |
NASDAQ |
May 02, 16:00
10.42
0.00 (0.00%)
After-Hours: 16:03
Amicus Therapeutics Accounts Payable (Quarterly): 15.12M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 15.12M |
September 30, 2023 | 23.15M |
June 30, 2023 | 13.52M |
March 31, 2023 | 24.96M |
December 31, 2022 | 15.41M |
September 30, 2022 | 12.05M |
June 30, 2022 | 23.11M |
March 31, 2022 | 22.91M |
December 31, 2021 | 21.51M |
September 30, 2021 | 24.47M |
June 30, 2021 | 13.76M |
March 31, 2021 | 16.11M |
December 31, 2020 | 17.06M |
September 30, 2020 | 14.76M |
June 30, 2020 | 14.31M |
March 31, 2020 | 16.24M |
December 31, 2019 | 21.72M |
September 30, 2019 | 81.48M |
June 30, 2019 | 84.12M |
March 31, 2019 | 60.60M |
December 31, 2018 | 6.606M |
September 30, 2018 | 54.33M |
June 30, 2018 | 41.61M |
March 31, 2018 | 43.68M |
December 31, 2017 | 7.867M |
Date | Value |
---|---|
September 30, 2017 | 53.71M |
June 30, 2017 | 35.64M |
March 31, 2017 | 39.64M |
December 31, 2016 | 12.90M |
September 30, 2016 | 29.01M |
June 30, 2016 | 23.83M |
March 31, 2016 | 22.50M |
December 31, 2015 | 16.48M |
September 30, 2015 | 30.56M |
June 30, 2015 | 16.90M |
March 31, 2015 | 15.83M |
December 31, 2014 | 5.874M |
September 30, 2014 | 11.33M |
June 30, 2014 | 9.918M |
March 31, 2014 | 9.167M |
December 31, 2013 | 2.146M |
September 30, 2013 | 8.166M |
June 30, 2013 | 9.018M |
March 31, 2013 | 6.427M |
December 31, 2012 | 2.115M |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | 2.576M |
September 30, 2011 |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
12.05M
Minimum
Sep 2022
84.12M
Maximum
Jun 2019
25.04M
Average
17.06M
Median
Dec 2020
Accounts Payable (Quarterly) Benchmarks
TG Therapeutics Inc | -- |
Geron Corp | 6.161M |
Vanda Pharmaceuticals Inc | 7.145M |
Fate Therapeutics Inc | 4.719M |
Editas Medicine Inc | 8.269M |